entertainment -WSS

entertainment

author：comprehensive 2025-10-02 22:57:39 - browse：88852

STAT's Megan Molteni speaks with Feng Zhang in New York on March 21, 2024 — Scientist Feng Zhang, right, is interviewed by reporter Megan Molteni at STAT's Breakthrough Summit East. STAT

When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas Medicine seemed like the pacesetter. It locked up some of the crucial IP, and had behind it the pioneering scientist Feng Zhang of the Broad Institute as one of its founders.

But now, a decade later, Editas is seen as lagging behind its peers. CRISPR Therapeutics, in partnership with Vertex Pharmaceuticals, won the race to get the first CRISPR-based medicine across the finish line. Intellia Therapeutics was the first to show that CRISPR editing could be performed inside the body. Editas, meanwhile, has seen a revolving door among its executives.

So what happened?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Biotech lab space demand falls sharply

knowledge

focus

WSS

Mass General totes up its waste in a move to tackle climate change

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Driven by the pandemic, applicants flood public health schools

Lasker Awards 2023: Winners in biomedical research

CommonSpirit Health keeps growing, even as it loses money

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

hotspot

entertainment

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Changes to biosimilar regulatory framework must prioritize patients

How to save PrEP access — and even expand it

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Affirmative action in medical school literally saved lives

Microbiome research is starting to find links to chronic diseases

Jerome Adams on the need for new antivirals for Covid

I learned firsthand about improving diversity in clinical trials

Trump demands the U.S. pay no more for drugs than other countries … again

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

knowledge

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

7 more heat

FDA panel to weigh approval of NurOwn, controversial ALS drug

CommonSpirit Health keeps growing, even as it loses money

Drug for rare kidney disease narrowly misses mark in clinical trial

Microbiome research is starting to find links to chronic diseases

Wikipedia

knowledge

focus

hotspot